Semaglutide
SELECT
Novo Nordisk · Phase 3 · Completed · Enrollment 17604
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide | n/r | n/r | n/r | n/r | n/r |
| Placebo (semaglutide) | 337 participants | 87 participants | 353 participants | n/r | 460 |
A count stays a count. This page does not turn a count into a percent.